Consulting and Scientific Advisory Board AgreementConsulting and Scientific Advisory Board Agreement • August 7th, 2012 • Aveo Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This Consulting and Scientific Advisory Board Agreement (the “Agreement”), shall be effective as of January 1, 2012 (the “Effective Date”), and is entered into by AVEO Pharmaceuticals, Inc., a Delaware corporation with a business address at 75 Sidney Street, Cambridge, MA 02139 (the “Company”), and Lynda Chin, MD of 2421 Inwood, Houston, Texas 77019 (the “Advisor”).
CONSULTING AND SCIENTIFIC ADVISORY BOARD AGREEMENTConsulting and Scientific Advisory Board Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS CONSULTING AGREEMENT effective as of October 31, 2018 (the “Effective Date”), is between GRI Bio, Inc. (the “Company”), and Vipin Kumar Chaturvedi personally or through Vidur Discoveries LLC (the “Consultant”).
CONSULTING AND SCIENTIFIC ADVISORY BOARD AGREEMENTConsulting and Scientific Advisory Board Agreement • August 16th, 2021 • Cocrystal Pharma, Inc. • Pharmaceutical preparations • Washington
This Agreement, dated as of April 13, 2021, is made and entered into by and between Cocrystal Discovery, Inc., a Delaware corporation (the “Company”) and Roger Kornberg, an individual whose principal residence is in California (“Advisor”).
THIS CONSULTING AND SCIENTIFIC ADVISORY BOARD AGREEMENT effectiveConsulting and Scientific Advisory Board Agreement • August 31st, 2018
as of July 20th, 2017 (the “Effective Date”), between Pyramidian Technology Group, Inc., or (“PYTG”) having its principal place of business at 2645 Executive Park Drive, Suite163 Weston, FL 33331 “Company”), a Nevada corporation and
